What Is INCY Fair Value?
Incyte (INCY) fair value estimate using multiple valuation models, updated daily.
As of August 29, 2026, Incyte (INCY) has a composite fair value estimate of $81.78 based on four valuation models: DCF (41% weight), Graham Number (29% weight), PEG (29% weight), and DDM (0% weight). The current market price is $124.37, suggesting the stock is overvalued by 34.2%.
Data as of August 29, 2026 (today)
Composite Fair Value
Overvalued3 of 4 models$81.78
vs. current price of $124.37(-34.2%)
How Is INCY Fair Value Calculated?
Four independent models estimate what INCY is worth. Each uses different inputs and assumptions. The composite blends them by weight.
INCY Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
41% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$117.51
-5.5%Fair Value
Inputs used
DDM (Dividend Discount Model)
0% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
N/A
This stock does not pay a dividend, so the DDM cannot be applied. The composite adjusts by redistributing this weight to the other models.
INCY Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
29% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$49.71
-60.0%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
29% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$34.79
-72.0%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $124.37 is 5.5% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $1.24B | $1.14B |
| Year 2 | $1.30B | $1.10B |
| Year 3 | $1.37B | $1.06B |
| Year 4 | $1.44B | $1.03B |
| Year 5 | $1.51B | $991.9M |
| Year 6 | $1.58B | $958.0M |
| Year 7 | $1.66B | $925.2M |
| Year 8 | $1.74B | $893.5M |
| Year 9 | $1.83B | $862.9M |
| Year 10 | $1.92B | $833.4M |
| Terminal Value | $31.68B | $13.73B |
What Are INCY's Key Financial Metrics?
Earnings & Growth
Current Price
$124.37
EPS (TTM)
$7.65
Forward P/E
13.9
Profit Margin
27.7%
Cash & Balance Sheet
Free Cash Flow
1.2B
EBITDA
1.9B
Book Value
$31.57
Total Debt
38.3M
What Do Analysts Say About INCY?
Low
$86.00
Average
$127.13
High
$155.00
Upside
+2.2%
INCY Fair Value FAQ
What is the fair value of INCY?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), INCY's estimated fair value is $81.78. The stock is currently trading at $124.37, which makes it overvalued by our analysis.
How is INCY's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is INCY overvalued or undervalued?
Based on our analysis, INCY is overvalued. The current price of $124.37 is 34.2% above our estimated fair value of $81.78.
What do Wall Street analysts say about INCY?
24 analysts cover Incyte with a consensus rating of "Buy." The average price target is $127.13, ranging from $86.00 to $155.00. This implies 2.2% upside from the current price.